Particle.news

Download on the App Store

Graphene Oxide Deemed Safe in First Human Clinical Trial

A landmark study reveals that controlled inhalation of ultra-pure graphene oxide poses no short-term health risks, paving the way for its broader application in medical and technological fields.

Image
Graphene Danger Art Concept
First human trial confirms safe advancement of 'wonder' nanomaterial
Image

Overview

  • The study, a collaboration between the Universities of Edinburgh and Manchester, marks the first controlled human exposure to graphene oxide.
  • Volunteers showed no adverse effects on lung function, blood pressure, or cardiovascular health after inhaling the material.
  • Researchers observed a minor change in blood clotting, but emphasized its insignificance.
  • Further research is needed to assess the effects of longer exposure and different forms of graphene.
  • The findings could lead to the development of new medical treatments and devices, with minimal risk to human health.